Position Summary
The Scientist, Pharmacology and Toxicology, reporting to the Sr. Director of Pharmacology & Toxicology is an individual contributor who works in a team environment (toxicology, pharmacology, medical/clinical, regulatory, CMC) in biotech drug discovery and development. The position includes study design and monitoring, development of relationships with toxicology CROs and university discovery pharmacology activities, data review, data interpretation, and data presentations. This includes exploratory studies and GLP studies to support regulatory filings. In addition, the role will liaise with discovery and development colleagues and participate in development of the overall toxicology and pharmacology strategies. The role will contribute strategically to the development of assets including presenting these strategies to the asset development team as needed to ensure alignment. This role will also work with external partners such as CROs to conduct the necessary studies to support drug development and to monitor study progress.
Key Responsibilities
Education & Qualifications
Travel
This role is expected to be on site 3 days per week. You will be expected to travel periodically based on the needs of the business to the extent requested by the Company, including attendance at Together Weeks, Together Days, and functional meetings as requested by the Company.
Company Overview:
MBX Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company's pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism preparing for Phase 3 development; and an obesity portfolio that includes MBX 4291 in Phase 1 development and MBX 5765 in preclinical development, as well as additional discovery candidates. The Company is based in Carmel, Indiana and Burlington, Massachusetts. To learn more, please visit the Company website at www.mbxbio.com and follow it on LinkedIn.
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.